Carcinoma Breast

12 registered clinical trials studyying Carcinoma Breast — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Withdrawn	Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs NCT04985357	Travera Inc	—
Recruiting	Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT) NCT06806930	George Washington University	Phase 2
Active Not Recruiting	Dosimetric Comparison of Target Volume, Heart and Left Lung in Post Mastectomy Radiotherapy (RT) of Left Sided NCT06746142	Nishat Tasnim	N/A
Unknown	Vinorelbine Metronomic Chemotherapy Combined With Hypofractionated Radiotherapy, PD-1/PD-L1 Sequential GM-CSF NCT05603013	Second Affiliated Hospital of Soochow University	Phase 2
Unknown	Identifying Biomarkers for Chronic Pain After Breast Cancer Treatment. NCT05507034	Universiteit Antwerpen	—
Completed	Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx) NCT05461430	Travera Inc	—
Recruiting	Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast Cancer NCT04790305	Fudan University	Phase 4
Active Not Recruiting	Study of the Safety and Efficacy of a Caffeine-based Antifibrosis Cream in Patients With Breast Cancer Undergo NCT03768492	NYU Langone Health	Phase 2
Completed	Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery NCT03113825	Avelas Biosciences, Inc.	Phase 2
Completed	CPG 7909 Plus Herceptin® In Patients With Metastatic Breast Cancer NCT00043394	Pfizer	Phase 2
Completed	Randomized Trial on Intraoperative Radiotherapy Full Dose Vs External Radiotherapy NCT01849133	European Institute of Oncology	N/A
Completed	Ten Years Results of a Score System to Address Adjuvant Therapies After Breast Conserving Surgery for Ductal C NCT03002766	Fondazione IRCCS Istituto Nazionale dei Tumori, Milano	Phase 2